Partner With Us NRI

Company details

6M Return -9.39%
1Y Return 10.88%
Mkt Cap.(Cr) 37,722.29
Volume 698
Div Yield 1.53%
OI Chg %
Volume 698

Open Free Demat Account Online with ICICIDIRECT


  • swot

  • technicals

  • deals

  • shareholding


Delivery and volume

Our Research View

Trading recommendation

Data not found

Investment recommendation

New power-brands drive growth; legacy brands steady…

Call Date

18 May 2022

Entry Price


Target Price



12-18 Month


  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio


Operating Profit(Cr.)

Profit after Tax(Cr.)


Reserves and Surplus



Operating Profit

Profit after tax





Equity Capital: 2,602.16 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 22,733.13 -37,122.02
LAST 3M 77,375.96 -51,746.13
LAST 6M 142,231.38 -195,441.57
LAST 12M 206,053.08 -175,138.09


  • About Company
  • Company Info
  • Listing Info
  • Abbott India Limited is a pharmaceutical company and has a market capitalization of Rs. 40,158.27 crores as of 25th August 2021. The company has reported its revenue income from operations of Rs. 4,310 crores at the end of March 2021. The Bombay Stock Exchange (BSE) and National Stock Exchange have assigned the number 500488 and scrip code ABBOTINDIA. As of 25th August 2021, Abbott India Limited was trading at Rs. 18,898.90.

    Abbott India Limited was a subsidiary of Abbott Laboratories, USA. Since 1944 they are working for the advancement of healthcare in India. It was incorporated on 22nd August '1944 as Boots Pure Drug Company (India) Ltd. In July '2002, they have changed their name to Abbott India Ltd. The company features a headquarters in north suburban Chicago; they serve in additional than 160 countries with leading medical devices, diagnostics, nutrition products, and branded generic medicines. The company has 3,585 permanent employees on the roll. The Promoter & Promoter group holding in the company has remained constant since the last year, i.e., 74.99%. The Balance of 25.01% is by others which involve Mutual Funds (3.42%), Venture Capital Funds (0.13%), foreign portfolio investors (0.25%), Financial Institutions/Banks (0.42%), Insurance Companies (1.96%), and non-Institutions (18.03%).

    In June 2021, the company has a profit of Rs. 195.76 crores, which had increased by 7.87% from Rs. 180.35 crores in the quarter ending June’20. From Rs. 279.04 crores in March 2020, Abbott India Limited EPS has risen to Rs. 325.04 crores in March 2021. EBIDTA margin has also increased by 23.3% in 2021 (Rs. 1,002 crores) compared to 2020 (Rs. 871 crores). Abbott India Limited stock closed at Rs. 18,806.75 on 23rd August '2021 (NSE) and has a return of 25.77% in the last six months (On 23rd March 2021 stock market price Rs. 13,959.80) and 35.36% in the previous year. Book value per share has increased to 1,225 in FY 2020-21 from 1,144 in FY 2019-20. The interest coverage ratio has been decreased to 51.7 times in FY 2020-21 from 95.1 times in FY 2019-20 due to the accounting impact of IND AS 116 –Lease.

Read More

Registered Address

Unit No 3 Corporate Park, Sion Trombay Road Chembur, Mumbai, Maharashtra, 400071

Tel : 91-22-67978888/50461000/2000/1119
Email : investorrelations.india:abbott.com
Website : http://www.abbott.co.in


Sharepro Services India P Ltd

AGM Date (Month) : Jul
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 500488
Book Closure Date (Month) : Jul
BSE Group : A
ISIN : INE358A01014

ICICIdirect Abbott India Ltd FAQ

You can buy Abbott India Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Abbott India Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 23, 2022 04:01 PM the closing price of Abbott India Ltd was ₹ 17,752.50.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 23, 2022 04:01 PM, the market cap of Abbott India Ltd stood at ₹ 37,722.29.
The latest PE ratio of Abbott India Ltd as of May 23, 2022 04:01 PM is 47.82
The latest PB ratio of Abbott India Ltd as of May 23, 2022 04:01 PM is 0.07
The 52-week high of Abbott India Ltd is ₹ 23,902.30 while the 52-week low is ₹ 15,525.00 .
According to analyst recommendations, Abbott India Ltd has a “Buy” rating for the long term.

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote